Literature DB >> 23959343

Insulin and glucagon signaling in the central nervous system.

Beatrice M Filippi, Mona A Abraham, Jessica T Y Yue, Tony K T Lam.   

Abstract

The prevalence of the obesity and diabetes epidemic has triggered tremendous research investigating the role of the central nervous system (CNS) in the regulation of food intake, body weight gain and glucose homeostasis. This invited review focuses on the role of two pancreatic hormones--insulin and glucagon--that trigger signaling pathways in the brain to regulate energy and glucose homeostasis. Unlike in the periphery, insulin and glucagon signaling in the CNS does not seem to have opposing metabolic effects, as both hormones exert a suppressive effect on food intake and weight gain. They signal through different pathways and alter different neuronal populations suggesting a complementary action of the two hormones in regulating feeding behavior. Similar to its systemic effect, insulin signaling in the brain lowers glucose production. However, the ability of glucagon signaling in the brain to regulate glucose production remains unknown. Future studies that aim to dissect insulin and glucagon signaling in the CNS that regulate energy and glucose homeostasis could unveil novel signaling molecules to lower body weight and glucose levels in obesity and diabetes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23959343     DOI: 10.1007/s11154-013-9258-4

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  130 in total

1.  Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.

Authors:  G F Lewis; M Vranic; P Harley; A Giacca
Journal:  Diabetes       Date:  1997-07       Impact factor: 9.461

2.  Inhibition of hypothalamic neuropeptide Y gene expression by insulin.

Authors:  M W Schwartz; A J Sipols; J L Marks; G Sanacora; J D White; A Scheurink; S E Kahn; D G Baskin; S C Woods; D P Figlewicz
Journal:  Endocrinology       Date:  1992-06       Impact factor: 4.736

3.  Effect of intracerebroventricularly infused glucagon on feeding behavior.

Authors:  A Inokuchi; Y Oomura; H Nishimura
Journal:  Physiol Behav       Date:  1984-09

4.  Effect of centrally administered glucagon on blood glucose levels in dogs.

Authors:  G C Agarwala; S K Bapat
Journal:  Indian J Med Res       Date:  1977-08       Impact factor: 2.375

5.  Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men.

Authors:  N Geary; H R Kissileff; F X Pi-Sunyer; V Hinton
Journal:  Am J Physiol       Date:  1992-06

6.  Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity.

Authors:  Marciane Milanski; Giovanna Degasperi; Andressa Coope; Joseane Morari; Raphael Denis; Dennys E Cintra; Daniela M L Tsukumo; Gabriel Anhe; Maria E Amaral; Hilton K Takahashi; Rui Curi; Helena C Oliveira; José B C Carvalheira; Silvana Bordin; Mário J Saad; Lício A Velloso
Journal:  J Neurosci       Date:  2009-01-14       Impact factor: 6.167

7.  Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.

Authors:  A Christine Könner; Ruth Janoschek; Leona Plum; Sabine D Jordan; Eva Rother; Xiaosong Ma; Chun Xu; Pablo Enriori; Brigitte Hampel; Gregory S Barsh; C Ronald Kahn; Michael A Cowley; Frances M Ashcroft; Jens C Brüning
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

8.  PDK1-Foxo1 in agouti-related peptide neurons regulates energy homeostasis by modulating food intake and energy expenditure.

Authors:  Yongheng Cao; Masanori Nakata; Shiki Okamoto; Eisuke Takano; Toshihiko Yada; Yasuhiko Minokoshi; Yukio Hirata; Kazunori Nakajima; Kristy Iskandar; Yoshitake Hayashi; Wataru Ogawa; Gregory S Barsh; Hiroshi Hosoda; Kenji Kangawa; Hiroshi Itoh; Tetsuo Noda; Masato Kasuga; Jun Nakae
Journal:  PLoS One       Date:  2011-04-07       Impact factor: 3.240

9.  Is insulin action in the brain clinically relevant?

Authors:  Beatrice M Filippi; Patricia I Mighiu; Tony K T Lam
Journal:  Diabetes       Date:  2012-04       Impact factor: 9.461

10.  Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake.

Authors:  Darleen A Sandoval; Didier Bagnol; Stephen C Woods; David A D'Alessio; Randy J Seeley
Journal:  Diabetes       Date:  2008-05-16       Impact factor: 9.461

View more
  16 in total

1.  Effects of overnight fasting on working memory-related brain network: an fMRI study.

Authors:  Natalia Chechko; Sebastian Vocke; Ute Habel; Timur Toygar; Lisa Kuckartz; Mark Berthold-Losleben; Zacharias G Laoutidis; Stelios Orfanos; Annette Wassenberg; Wölfram Karges; Frank Schneider; Nils Kohn
Journal:  Hum Brain Mapp       Date:  2014-11-12       Impact factor: 5.038

2.  Duodenal-Jejunal Bypass Ameliorates Type 2 Diabetes Mellitus by Activating Insulin Signaling and Improving Glucose Utilization in the Brain.

Authors:  Na Li; Qing-Tao Yan; Qi Jing; Rui-Yan Pan; Huai-Jie Wang; Bin Jiang; Xian-Jun Li; Yi Wang; Jun-Hong Dong; Xue-Jian Wang; Mei-Jia Zhang; Qing-Guo Meng; Xiang-Zhen Li; Zhi-Jun Liu; Zhi-Qin Gao; Mei-Hua Qu
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

3.  Effects of site-directed mutagenesis of GLP-1 and glucagon receptors on signal transduction activated by dual and triple agonists.

Authors:  Sanaz Darbalaei; Ru-Lue Chang; Qing-Tong Zhou; Yan Chen; An-Tao Dai; Ming-Wei Wang; De-Hua Yang
Journal:  Acta Pharmacol Sin       Date:  2022-08-11       Impact factor: 7.169

Review 4.  Knockout mouse models of insulin signaling: Relevance past and future.

Authors:  Anne E Bunner; P Charukeshi Chandrasekera; Neal D Barnard
Journal:  World J Diabetes       Date:  2014-04-15

Review 5.  ApoE and cerebral insulin: Trafficking, receptors, and resistance.

Authors:  Elizabeth M Rhea; Jacob Raber; William A Banks
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

6.  Interoception as modeling, allostasis as control.

Authors:  Eli Sennesh; Jordan Theriault; Dana Brooks; Jan-Willem van de Meent; Lisa Feldman Barrett; Karen S Quigley
Journal:  Biol Psychol       Date:  2021-12-20       Impact factor: 3.111

7.  Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hormones of energy balance in a TCDD-sensitive and a TCDD-resistant rat strain.

Authors:  Jere Lindén; Sanna Lensu; Raimo Pohjanvirta
Journal:  Int J Mol Sci       Date:  2014-08-12       Impact factor: 5.923

8.  Mediobasal hypothalamic overexpression of DEPTOR protects against high-fat diet-induced obesity.

Authors:  Alexandre Caron; Sébastien M Labbé; Damien Lanfray; Pierre-Gilles Blanchard; Romain Villot; Christian Roy; David M Sabatini; Denis Richard; Mathieu Laplante
Journal:  Mol Metab       Date:  2015-12-08       Impact factor: 7.422

Review 9.  Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy.

Authors:  Velimir Altabas; Vanja Zjačić-Rotkvić
Journal:  Immunotargets Ther       Date:  2015-07-09

10.  Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy.

Authors:  Cecilia Follin; Sanaz Gabery; Åsa Petersén; Pia C Sundgren; Isabella Björkman-Burtcher; Jimmy Lätt; Peter Mannfolk; Eva Marie Erfurth
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.